Skip to main content

Advertisement

Log in

Aktivierung neutrophiler Granulozyten während Ischämie der Lunge und Reperfusion nach Transplantation: Effekt der Konservierungslösungen Euro-Collins und Low-Potassium-Dextran

Neutrophil activation during ischemia and reperfusion after lung transplantation

  • Originalarbeit
  • Published:
Zeitschrift für Herz-, Thorax- und Gefäßchirurgie Aims and scope

Zusammenfassung

Hauptursache der frühen Morbidität und Mortalität nach Lungentransplantation ist das primäre Transplantatversagen hervorgerufen durch einen Ischämie-Reperfusions-Schaden. Am Modell der allogenen orthotopen unilateralen Lungentransplantation am Schwein haben wir den Einfluß der Lungenkonservierung mit Euro Collins- oder Low-Potassium-Dextran (LPD) Lösung auf den Ischämie-Reperfusions-Schaden und die Aktivierung neutrophiler Granulozyten (PMN) untersucht. Spender- und Empfängertiere wurden in 3 experimentelle Gruppen randomisiert. EC-Gruppe (n=6): In situ Flush-Perfusion mit modifizierter Euro-Collins (EC) Lösung: EC+PTX-Gruppe (n=6): Perfusion mit EC unter Zusatz von Pentoxifyllin (300 mg/l) zur Inhibierung der Leukozytenaktivierung; LPD-Gruppe (n=6): Flush-Perfusion mit LPD (Perfadex) Lösung (100 ml/kg). Nach 18 h Ischämie (4 °C) wurde eine linksseitige unilaterale Transplantation durchgeführt und während 6 h Reperfusion die Lungenfunktion gemessen. Der oxidative Lungenschaden, quantifiziert anhand der Lipidperoxidation (Thiobarbitursäure-reaktive Substanzen (TBARM) in der bronchoalveolären Lavage) und die Ausbildung eines Lungenödems, gemessen als Lungenfeucht/Lungentrockengewichts-Verhältnis (W/D ratio) am Ende der 6stündigen Reperfusion waren sowohl in der EC+PTX als auch in der LPD-Gruppe signifikant geringer als in der EC-Gruppe. Die Transplantatfunktion (arterieller PO2) war signifikant besser bei EC+PTX-konservierten Lungen als nach EC-Konservierung. Wir schließen aus unseren Ergebnissen: (1) Die Aktivierung neutrophiler Granulozyten spielt eine zentrale Rolle für die Ausbildung eines Ischämie-Reperfusions-Schadens nach Lungentransplantation. (2) Lungenkonservierung mit LPD-(Perfadex) Lösung resultiert in einer verminderten Leukozytenaktivierung und einem geringeren Ischämie-Reperfusions-Schaden nach Lungentransplantation.

Summary

The impact of pulmonary vascular flush preservation with Eurocollin’s (EC) solution or low-potassium-dextran (LPD) solution (Perfadex®) on ischemia reperfusion-injury after lung transplantation and the contribution of PMN leukocytes were assessed in an animal model of left-sided orthotopic single lung transplantation. Eighteen pairs of domestic pigs were randomized into three experimental groups: In the EC group (n=6) donor lungs were in situ flush perfused with modified EC solution; in the EC+PTX group (n=6), 300 mg/l of pentoxifylline (PTX) was added to the EC flush solution, and 12 mg/kg of PTX were injected intravenously shortly before reperfusion to inhibit PMN activation; in the LPD group (n=6) low potassium dextran solution (Perfadex®, 100 ml/kg) was used for flush. The duration of cold lung storage was 18 hours. After reimplantation recipient animals were monitored during 6 h of reperfusion. Lung oxidant injury, as evidenced by increased lung wet/dry weight ratios (p<0.05, ANOVA), and lung lipid peroxidation (p<0.01), and PMN accumulation in broncho-alveolar lavage (BAL) fluids (p<0.05) during reperfusion were lower in both the EC+PTX and LPD groups as compared to the EC group. This was paralleled by significantly improved graft function (PaO2) in both the EC+PTX and LPD groups as compared to the EC group (p<0.05). In summary, our results showed that (1) PMN contribute significantly to lung injury during reperfusion following ischemia and lung transplantation, and (2) LPD-preserved lungs as compared to EC-preserved lungs show reduced PMN activation and better early graft function after lung transplantation. Our results suggest that the use of LPD-flush perfusion for lung preservation may result in a reduced incidence of lung ischemia-reperfusion injury after lung transplantation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Al-Khalidi UAS, Chaglassian TH (1965) The species distribution of xanthine oxidase. Biochem J 97: 318–320

    PubMed  CAS  Google Scholar 

  2. Aziz S, Suzuki K, Rice G, Reichenbach DD (1996) Prolongation of discordant cardiac xenotransplantation survival by Lisofylline, a phosphatidic acid inhibitor. Transplant Proc 28: 740

    PubMed  CAS  Google Scholar 

  3. Breda MA, Hall TS, Stuart RS (1985) Twenty-four hour lung preservation by hypothermia and leukocyte depletion. J Heart Transpl 4: 325–329

    CAS  Google Scholar 

  4. Chapelier A, Reignier J, Mazmanian M, Dulmet E, Libert JM, Dartevelle P, Barbotin F, Herve P (1995) Amelioration of reperfusion injury by pentoxfylline after lung transplantation. The Universite Paris-Sud Lung Transplant Group. J Heart Lung Transplant 14: 676–683

    PubMed  CAS  Google Scholar 

  5. Cooper JD, Vreim CE (1992) NHLBI workshop summary. Biology of lung preservation for transplantation. Am Rev Respir Dis 146: 803–807

    PubMed  CAS  Google Scholar 

  6. Cooper JD (1996) St. Louis International Lung Transplant Registry — April 1996 Report

  7. Hammerschmidt DE, Kotasek D, McCarthy T, Huh PW, Freyburger G, Vercellotti GM (1988) Pentoxifylline inhibits granulocyte and platelet function, including granulocyte priming by platelat activating factor. J Lab Clin Med 112: 254–263

    PubMed  CAS  Google Scholar 

  8. Kennedy TP, Rao NV, Hopkins C, Pennigton L, Tolley E, Hoidal JR (1989) Role of reactive oxygen species in reperfusion injury in the rabbit lung. J Clin Invest 83: 1326–1335

    Article  PubMed  CAS  Google Scholar 

  9. Matsuzaki Y, Waddell TK, Puskas JD, Hirai T, Nakajima S, Slutsky AS, Patterson GA (1993) Amelioration of postischemic lung reperfusion injury by prostaglandin E1. Am Rev Respir Dis 148: 882–889

    PubMed  CAS  Google Scholar 

  10. Novick RJ, Menkis AH, McKenzie FN (1992) New trends in lung preservation: a collective review. J Heart Lung Transplant 11: 377–392

    PubMed  CAS  Google Scholar 

  11. Okabayashi K, Aoe M, De Meester SR, Cooper JD, Patterson GA (1994) Pentoxifylline reduces lung allograft reperfusion injury. Ann Thorac Surg 58: 50–56

    PubMed  CAS  Google Scholar 

  12. Oosterhoff Y, Noordhek JA, Petersen AH, Kauffman HF, Postma DS, Prop J (1992) There is no activation of O2-production by alveolar macrophages and neutrophil polymorphonuclear leukocytes in rat lung transplants during the reimplantation response and acute rejection. Am Rev Respir Dis 145: 1155–1159

    PubMed  CAS  Google Scholar 

  13. Paull DE, Keagy BA, Kron EJ, Wilcox BR (1989) Reperfusion injury in the lung preserved for 24 hours. Ann Thorac Surg 47: 187–192

    PubMed  CAS  Google Scholar 

  14. Puskas JD, Cardoso PF, Mayer E, Shi S, Slutsky AS, Patterson GA (1992) Equivalent eighteen-hour lung preservation with low-potassium dextran or Euro-Collins solution after prostaglandin E1 infusion. J Thorac Cardiovasc Surg 104: 83–89

    PubMed  CAS  Google Scholar 

  15. Shi Y, Kornovski BS, Savani R, Turley EA (1993) A rapid, multiwell colorimetric assay for chemotaxis. J Immunol Method 164: 149–154

    Article  CAS  Google Scholar 

  16. Steen S, Kimblad PO, Sjöberg T, Lindberg L, Ingemansson R, Massa G (1994) Safe lung preservation for twenty-four hours with Perfadex. Ann Thorac Surg 57: 450–457

    Article  PubMed  CAS  Google Scholar 

  17. Steen S, Sjöberg T, Massa G, Ericsson L, Lindberg L (1993) Safe pulmonary preservation for 12 hours with low-potassium-dextran solution. Ann Thorac Surg 55: 434–440

    PubMed  CAS  Google Scholar 

  18. Steimle CN, Guynn TP, Morganroth ML, Bolling SF, Carr K, Deeb GM (1992) Neutrophils are not necessary for ischemia-reperfusion lung injury. Ann Thorac Surg 53: 64–72

    Article  PubMed  CAS  Google Scholar 

  19. Takeda K, Shimada Y, Amano M, Sakai T, Okada T, Yoshida I (1984) Plasma lipidperoxides and alpha-tocopherol in critical ill patients. Crit Care Med 12: 957–959

    Article  PubMed  CAS  Google Scholar 

  20. Wang LS, Nakamoto K, Hsieh CM, Miyoshi S, Cooper JD (1993) Influence of temperature of flushing solution on lung preservation. Ann Thorac Surg 55: 711–715

    Article  PubMed  CAS  Google Scholar 

  21. Xiong L, Mazmanian M, Chapelier AR et al. (1994) Lung preservation with Euro-Collins, University of Wisconsin, Wallwork, and low-potassium-dextran solution. University Paris-Sud Lung Transplant Group. Ann Thorac Surg 58: 845–850

    Article  PubMed  CAS  Google Scholar 

  22. Yamashita M, Schmid RA, Okabayashi K, Patterson GA (1996) Pentoxifylline in flush solution improves early lung allograft function. Ann Thorac Surg 61: 1055–1061

    Article  PubMed  CAS  Google Scholar 

  23. Yonemaru M, Hatherill JR, Hoffmann H, Zheng H, Ishii K, Raffin TA (1991) Pentoxifylline does not attenuate acute lung injury in the absence of granulocytes. J Appl Physiol 71: 342–351

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hoffmann, H., Müller, C., Sakamaki, F. et al. Aktivierung neutrophiler Granulozyten während Ischämie der Lunge und Reperfusion nach Transplantation: Effekt der Konservierungslösungen Euro-Collins und Low-Potassium-Dextran. Z. Herz-, Thorax-, Gefäßchir. 11, 108–114 (1997). https://doi.org/10.1007/BF03042633

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03042633

Schlüsselwörter

Key words

Navigation